Clinical Trials Logo

Clinical Trial Summary

The study is a randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy.


Clinical Trial Description

The study consists of two treatment periods of 22 days with randomized CNV1014802 350mg or placebo administered twice daily. In addition, single blind placebo will be administered during a two week run-in, a two week wash-out period between the two treatment periods, and a one week run-out phase.

This study was previously posted by Convergence Pharmaceuticals, Ltd., which has been acquired by Biogen. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01561027
Study type Interventional
Source Biogen
Contact
Status Completed
Phase Phase 2
Start date April 30, 2011
Completion date August 31, 2012

See also
  Status Clinical Trial Phase
Completed NCT05654428 - Effects of Mackenzie Extension and William Flexion Exercises in Lumbo-sarcal Radiculopathy N/A
Terminated NCT01267825 - CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial Phase 4
Completed NCT02935608 - Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy Phase 2
Completed NCT03727100 - Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults Phase 3
Terminated NCT02951377 - Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy Phase 1
Completed NCT03776318 - Long-Term Follow-up Safety of Clonidine Micropellets
Active, not recruiting NCT04238793 - Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy Phase 1/Phase 2
Terminated NCT05614648 - Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet Phase 3
Completed NCT06058806 - Effects of Multimodal Physical Therapy in Patients With Lumbosacral Radiculopathy N/A
Enrolling by invitation NCT05613569 - A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
Completed NCT01917825 - A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy Phase 2
Recruiting NCT06167044 - Effect of Thoracic Mobilization on Lumbar Radiculopathy N/A
Completed NCT00826124 - Does Magnetic Resonance Imaging (MRI) Improve Interventional Outcomes for Lumbosacral Radiculopathy? N/A
Recruiting NCT06216288 - Effect of Combined Lumbar Traction and Repetitive Back Extension Exercise on H-reflex in Lumbosacral Radiculopathy N/A
Completed NCT04778592 - Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain Phase 2
Recruiting NCT05711121 - Caudal Versus S1 Transforaminal Epidural Steroid Injection for the Treatment of Unilateral S1 Radiculopathy N/A
Terminated NCT03514277 - A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief Phase 4
Completed NCT01655849 - Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy Phase 2
Terminated NCT01836770 - Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position. N/A
Completed NCT00733096 - A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy Phase 2/Phase 3